Shinnakasu R, Sakakibara S, Yamamoto H, Wang PH, et al. Glycan engineering of the SARS-CoV-2 receptor-binding domain elicits cross-neutralizing antibodies for SARS-related viruses. J Exp Med 2021;218.
PMID: 34623376